| Description | Fluphenazine Decanoate Dihydrochloride is an antipsychotic agent, it could block postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia. |
| molecular weight | 664.69 |
| Molecular formula | C32H46Cl2F3N3O2S |
| CAS | 2376-65-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Midha KK, Marder SR, Jaworski TJ, McKay G, Hubbard JW, Hawes EM, Van Putten T, Wirshing WC, Aravagiri M. Clinical perspectives of some neuroleptics through development and application of their assays. Ther Drug Monit. 1993 Jun;15(3):179-89. Review. PubMed PMID: 8101398. 2. Dudley J, Rauw G, Hawes EM, Keegan DL, Midha KK. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):791-5. PubMed PMID: 6686710. 3. Hinterhuber H, Platz T, Schwarz S. [The plasma prolactin level under fluphenazine treatment (author's transl)]. Wien Med Wochenschr. 1980 Sep 15;130(17):566-70. German. PubMed PMID: 7456470. 4. Whelpton R, Curry SH. Methods for study of fluphenazine kinetics in man. J Pharm Pharmacol. 1976 Dec;28(12):869-73. PubMed PMID: 12260. |